These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18622751)

  • 1. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
    Kontis D; Boulougouris V; Papakosta VM; Kalogerakou S; Papadopoulos S; Poulopoulou C; Papadimitriou GN; Tsaltas E
    Psychopharmacology (Berl); 2008 Nov; 200(4):597-610. PubMed ID: 18622751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology.
    Tsaltas E; Kontis D; Chrysikakou S; Giannou H; Biba A; Pallidi S; Christodoulou A; Maillis A; Rabavilas A
    Biol Psychiatry; 2005 May; 57(10):1176-85. PubMed ID: 15866558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder.
    Korff S; Stein DJ; Harvey BH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):348-55. PubMed ID: 17888556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Graham D; Amodeo S; Cheon P; Kirk A; Peel J; Taji L; Szechtman H
    Psychopharmacology (Berl); 2013 May; 227(2):277-85. PubMed ID: 23354534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Sharma R; Taji L; Cheon P; Peel J; Kirk A; Szechtman H
    Psychopharmacology (Berl); 2014 Sep; 231(18):3707-18. PubMed ID: 24682503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2C receptor involvement in the control of persistence in the reinforced spatial alternation animal model of obsessive-compulsive disorder.
    Papakosta VM; Kalogerakou S; Kontis D; Anyfandi E; Theochari E; Boulougouris V; Papadopoulos S; Panagis G; Tsaltas E
    Behav Brain Res; 2013 Apr; 243():176-83. PubMed ID: 23327741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Johnson E; Wong M; Szechtman H
    Behav Brain Res; 2015 Feb; 279():211-7. PubMed ID: 25449840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation.
    Woehrle NS; Klenotich SJ; Jamnia N; Ho EV; Dulawa SC
    Psychopharmacology (Berl); 2013 Jun; 227(3):545-51. PubMed ID: 23377022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.
    Kennett GA; Lightowler S; de Biasi V; Stevens NC; Wood MD; Tulloch IF; Blackburn TP
    Neuropharmacology; 1994 Dec; 33(12):1581-8. PubMed ID: 7760981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
    Hollander E; DeCaria C; Gully R; Nitescu A; Suckow RF; Gorman JM; Klein DF; Liebowitz MR
    Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Lactobacillus casei Consumption in Improvement of Obsessive-Compulsive Disorder: an Animal Study.
    Sanikhani NS; Modarressi MH; Jafari P; Vousooghi N; Shafei S; Akbariqomi M; Heidari R; Lavasani PS; Yazarlou F; Motevaseli E; Ghafouri-Fard S
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1409-1419. PubMed ID: 32124236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
    Baumann MH; Rutter JJ; Auerbach SB
    Neuropharmacology; 1993 Dec; 32(12):1381-6. PubMed ID: 8152528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of acoustic startle reactivity by cocaine administration during the postnatal period: comparison with a specific serotonin reuptake inhibitor.
    Dow-Edwards DL
    Neurotoxicol Teratol; 1996; 18(3):289-96. PubMed ID: 8725641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD.
    Eagle DM; Noschang C; d'Angelo LS; Noble CA; Day JO; Dongelmans ML; Theobald DE; Mar AC; Urcelay GP; Morein-Zamir S; Robbins TW
    Behav Brain Res; 2014 May; 264(100):207-29. PubMed ID: 24406720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder.
    S N U; J M V; N S J; P V D
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1161-6. PubMed ID: 19549549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway.
    Arora T; Bhowmik M; Khanam R; Vohora D
    Behav Brain Res; 2013 Jun; 247():146-52. PubMed ID: 23473877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
    Kreiss DS; Coffman CF; Fiacco NR; Granger JC; Helton BM; Jackson JC; Kim LV; Mistry RS; Mizer TM; Palmer LV; Vacca JA; Winkler SS; Zimmer BA
    Pharmacol Biochem Behav; 2013 Mar; 104():119-24. PubMed ID: 23333679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U; Merico A; Ermani M; Ori C
    Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
    Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M
    Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.